GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:EARS
Delisted

Auris Medical Holding AG Stock Price (Quote)

$0.750
-0.0010 (-0.133%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.680 $1.00 Friday, 27th May 2022 EARS stock ended at $0.750. This is 0.133% less than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 10.68% from a day low at $0.740 to a day high of $0.82.
90 days $0.635 $2.14
52 weeks $0.635 $4.58

Historical Auris Medical Holding AG prices

Date Open High Low Close Volume
2021-08-12 $3.11 $3.13 $3.03 $3.11 123 894
2021-08-11 $3.08 $3.17 $3.03 $3.10 220 723
2021-08-10 $3.05 $3.13 $3.01 $3.10 193 405
2021-08-09 $3.05 $3.10 $3.00 $3.04 156 012
2021-08-06 $3.19 $3.26 $2.96 $3.12 2 693 169
2021-08-05 $2.95 $3.10 $2.95 $3.01 375 532
2021-08-04 $3.08 $3.10 $2.88 $2.93 636 147
2021-08-03 $3.08 $3.87 $3.05 $3.17 11 957 353
2021-08-02 $3.01 $3.15 $3.01 $3.08 94 419
2021-07-30 $3.11 $3.18 $3.00 $3.02 117 075
2021-07-29 $3.04 $3.19 $3.03 $3.12 151 824
2021-07-28 $2.82 $3.22 $2.82 $3.14 222 493
2021-07-27 $2.87 $2.92 $2.76 $2.91 258 757
2021-07-26 $2.93 $3.07 $2.92 $2.95 140 901
2021-07-23 $3.08 $3.09 $3.00 $3.05 172 858
2021-07-22 $3.32 $3.35 $3.08 $3.10 391 349
2021-07-21 $3.01 $3.33 $2.97 $3.27 845 513
2021-07-20 $2.92 $3.03 $2.91 $3.03 185 648
2021-07-19 $2.89 $2.99 $2.80 $2.91 285 707
2021-07-16 $3.02 $3.04 $2.91 $2.94 303 079
2021-07-15 $3.08 $3.14 $2.93 $3.02 614 257
2021-07-14 $3.60 $3.63 $3.13 $3.15 2 788 584
2021-07-13 $3.26 $3.28 $3.15 $3.17 194 861
2021-07-12 $3.26 $3.27 $3.20 $3.22 79 095
2021-07-09 $3.33 $3.42 $3.21 $3.28 177 609
Click to get the best stock tips daily for free!

About Auris Medical Holding AG

Auris Medical Holding AG Auris Medical Holding AG, a clinical-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear disorders. Its lead product candidate includes AM-101, which is in Phase III clinical development for treating acute inner ear tinnitus. The company is also developing AM-111 for the treatment of acute sensorineural hearing loss; and other pre-clinical stage products comprising AM-102 and AM-123. It has... EARS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT